Indian Generics Firms Must Shift Gears For Third Wave, Says Lupin MD

 
• By Anju Ghangurde
  
Paths
MOVING BEYOND PLAIN GENERICS WILL BE CRITICAL SAYS LUPIN's MD, NILESH GUPTA
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business